Table 1. Characteristics of the selected cohort.
| NILM (N = 56) | LGSIL (N = 18) | HGSIL (N = 17) | TRUE (N = 91) | P-value * | |
|---|---|---|---|---|---|
| Age | |||||
| Mean (SD) | 40.4 (12.0) | 39.6 (9.55) | 33.9 (9.47) | 39.1 (11.3) | 0.213 |
| Median [Min, Max] | 38.5 [21.0, 60.0] | 38.5 [25.0, 56.0] | 33.0 [22.0, 56.0] | 37.0 [21.0, 60.0] | |
| BMI_Analysis | |||||
| Normal | 20 (35.7%) | 5 (27.8%) | 7 (41.2%) | 32 (35.2%) | NS |
| Obese | 18 (32.1%) | 8 (44.4%) | 5 (29.4%) | 31 (34.1%) | |
| Overweight | 18 (32.1%) | 4 (22.2%) | 5 (29.4%) | 27 (29.7%) | |
| Not recorded | 0 (0%) | 1 (5.6%) | 0 (0%) | 1 (1.1%) | |
| pH | |||||
| Mean (SD) | 5.50 (0.500) | 5.36 (0.413) | 5.60 (0.573) | 5.49 (0.500) | 0.486 |
| Median [Min, Max] | 5.50 [5.00, 7.00] | 5.25 [5.00, 6.00] | 5.50 [5.00, 6.50] | 5.50 [5.00, 7.00] | |
| HPV_Status | |||||
| HPV- | 27 (48.2%) | 1 (5.6%) | 2 (11.8%) | 30 (33.0%) | |
| HPV+ | 29 (51.8%) | 17 (94.4%) | 15 (88.2%) | 61 (67.0%) | 2.48EE-4 |
| HPV_Risk | |||||
| HPV- | 27 (48.2%) | 1 (5.6%) | 2 (11.8%) | 30 (33.0%) | 0.003 |
| Co-infection | 7 (12.5%) | 8 (44.4%) | 1 (5.9%) | 16 (17.6%) | 0.040 |
| High_Risk | 22 (39.3%) | 9 (50.0%) | 14 (82.4%) | 45 (49.5%) | 0.016 |
| CST | |||||
| I | 9 (16.1%) | 4 (22.2%) | 0 (0%) | 13 (14.3%) | |
| IV-A | 12 (21.4%) | 5 (27.8%) | 5 (29.4%) | 22 (24.2%) | |
| IV-C | 35 (62.5%) | 9 (50.0%) | 8 (47.1%) | 52 (57.1%) | |
| IV-B | 0 (0%) | 0 (0%) | 4 (23.5%) | 4 (4.4%) | 0.025 |
*Kruskal-Wallis’s test for continuous and Fisher’s test for categorical variables.